Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis

Immunobiology

Volumn 198, Issue 4, 1998, Pages 408-423

  Sedlacek, Radislav ^a   Mauch, Simon ^a   Kolb, Birgit ^a   Schätzlein, Christian ^b   Eibel, Hermann ^b   Peter, Hans Hartmut ^b   Schmitt, Jacky ^c   Krawinkel, Ulrich ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Elias GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE;

ARTICLE; HUMAN; HUMAN CELL; JOINT DESTRUCTION; LEUKEMIA CELL LINE; MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0031933377     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80049-1     Document Type: Article

References (50)

1. MATRISIAN, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. TIG 4: 121-125.
2. MAUVIEL, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53: 288-295.
3. BIRKEDAL-HANSEN, H., W. G. MOOR, M. K. BODDEN, L. J. WINDSOR, B. BIRKEDAL-HANSEN, A. DECARLO, and J. A. ENGLER. 1993. Matrix metalloproteinases: A review. Crit. Rev. Oral. Biol. Med. 4: 197-250.
4. CASE, J. P., R. LAFYATIS, E. F. REMMERS, G. K. KUMKUMIAN, and R. L. WILDER. 1989. Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am. J. Pathol. 135: 1055-1064.
5. KEYSZER, G. M., A. H. HEER, and S. GAY. 1994. Cytokines and oncogenes in cellular interactions with of rheumatoid arthritis. Stem Cells (Dayt) 12: 75-86.
6. ROMANIC, A. M., and J. A. MADRI. 1994 The induction of 72-kd gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125: 1165-1177.
7. LEPPERT, D., E. WAUBANT, R. GALARDY, N. W. BUNNETT, and S. L. HAUSER. 1995. T cell gelatinases mediate basement membrane transmigration on vitro. J. Immunol. 154: 4379-4389.
8. XIA, M., D. LEPPERT, S. L. HAUSER, S. P. SREEDHARAN, P. J. NELSON, A. M. KRENSKY, and J. GOETZEL. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156: 160-167.
9. FELDMANN, M., F. M. BRENNAN, and R. N. MAINI. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
10. MANETTI, R., P. PARRONCHI, M. G. GIUDZI, M.-P. PICCINNI, E. MAGGI, G. TRINCHIERI, and S. ROMAGNANI. 1993. Natural killer cell stimulatory factor (NKSF/II-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177: 1199-1204.
11. BUCHAN, G., K. BARRETT, M. TURNER, D. CHANTRY, R. N. MAINI, and M. FELDMANN. 1988. Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin. Exp. Immunol. 73: 449-455.
12. HIRANO, T., T. MATSUDA, M. TURNER, N. MIYASAKA, G. BUCHAN, B. TANG, K. SATO, M. SHIMIZU, M. MAINI, R. FELDMANN, and T. KISHIMOTO. 1988. Excessive production of interleukin-6/B cell stimulatory factor in rheumatoid arthritis. Eur. J. Immunol. 18: 1797-1801.
13. BRENNAN, F. M., C. O. C. ZACHARIAE, D. CHANTRY, C. G. LARSEN, M. TURNER, R. N. MAINI, K. MATSUSHIMA, and M. FELDMANN. 1990. Detection of interleukin 6 biological activity in synovial fluids from patients with rheumatoid arthritis and production of IL-8 by isolated synovial cells. Eur. J. Immunol. 20: 2141-2144.
14. HASTY, K., R. A. REIFE, A. H. KANG, and J. M. STUART. 1990. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 33: 388-397.
15. NGUYEN, Q., J. S. MORT, and P. J. ROUGHLEY. 1992. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J. Clin. Invest. 89: 1189-1197.
16. FIRESTEIN, G. S., M. M. PAINE, and B. H. LITTMAN. 1991. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 34: 1094-1105.
17. MCCAHREN, S. S. 1991. Expression of metalloproteinases and metalloproteinase inhibitors in human arthritic synovium. Arthritis Rheum. 34: 1085-1093.
18. OKADA, Y., H. NAGASE, and E. D. HARRIS, Jr. 1986. A metalloproteinase from human rheumatoid synovial fibroblasts that digest connective tissue matrix components. J. Biol. Chem. 261: 14245-14255.
19. MUERHY, G., M. I. COCKETT, R. V. WARD, and A. J. P. DOCHERTY. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan. A quantitative comparison of the activities of 95 kD and 72 kD gelatinases, stromelysins-1 and -2, and punctated metalloproteinase (PUMP). Biochem. J. 277: 277-279.
20. CHARRIERE, G., D. J. HARTMANN, E. VIGNON, M. C. RONZIERE, D. HERBAGE, and O. WILLE. 1988. Antibodies to type I, II, IX, XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum. 31: 325-332.
21. FOWLKES, J., J. J. ENGHILD, K. SUZUKI, and H. NAGASE. 1994. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269: 25742-25746.
22. TAIPALE, J., J. LOHI, J. SAARINEN, P. T. KOVANEN, and J. KESKI-OJA. 1995. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270: 4689-4696.
23. TAUB, D. D., and J. J. OPPENHEIM. 1993: Review of the chemokine meeting: the third international symposium of chemotactic cytokines. Cytokine 5: 175-179.
24. GEARING, A. J., P. BECKETT, M. CHRISTODOULOU, M. CHOURCHILL, J. CLEMENTS, A. H. DAVIDSON, A. H. DRUMMOND, W. A. GALLOWAY, R. GILBERT, J. L. GORDON, T. M. LEBER, M. MANGAN, K. MILLER, P. NAYEE, K. OWEN, S. PATEL, W. THOMAS, G. WELLS, L. M. WOOD, and K. WOOLEY. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370: 555-557.
25. KAYAGAKI, N., A. KAWASAKI, T. EBATA, H. OHMOTO, S. IKEDA, S. INOUE, K. YOSHIMO, K. OKUMURA, and H. YAGITA. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182: 1777-1783.
26. ARNETT, F. C., S. M. EDWORTHY, D. A. BLOCH, D. J. MCSHANE, J. F. FRIES, T. A. MEDSGER, D. M. MITCHELL, D. H. NEUSTADT, R. S. PINALS, J. G. SCHALLER, J. T. SHARP, R. L. WILDER, and G. G. HUNDER. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 515-525.
27. TAN, E. M., A. S. COHEN, J. F. FRIES, A. T. MASI, D. J. MCSHANE, N. F. ROTHFIELD, J. G. SCHALLER, N. TALAL, and R. J. WINCHESTER. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
28. MASI, A. T., G. P. RODNAN, T. A. MEDSGER, R. D. ALTMAN, W. A. D'ANGELO, J. F. FRIES, E. C. LEROY, A. B. G. KIRSNER, D. J. MCSHANE, A. R. MYERS, and G. C. SHARP. 1981. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull. Rheum. Dis. 31: 1-6.
29. ADAMS, M. E., D. Q. HUANG, L. Y. YAO, and L. J. SANDELL. 1992. Extraction and isolation of mRNA from adult articular cartilage. Anal. Biochem. 202: 89-95.
30. AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN, J. A. SMITH, and K. STRUHL. 1991. Current protocols in molecular biology. Wiley Interscience, New York.
31. MARTIN, R., C. HOOVER, S. GRIMME, S. GROGAN, J. HÖLTKE, and C. KESSLER. 1990. A highly sensitive, non-radioactive DNA labeling and detection system. BioTechniques 9: 762-768.
32. ALTSCHUL, S. F., W. GISH, W. MILLER, E. W. MYERS, and D. J. LIPMAN. 1990. Basic local alignment tool. J. Mol. Biol. 215: 403-410.
33. ATHERTON, E., C. J. LOGAN, and R. C. SHEPPARD. 1981. Peptide synthesis Part 2. Procedures for solid phase synthesis using Nα-fluorenylmethysoxycarbamylamino-acid on poly-imid supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Lond. Perkin. Trans. 1: 538.
34. GASSMANN, M., P. THÖMMES, T. WEISER, and U. HÜBSCHER. 1990. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4: 2528-2532.
35. ROLFE, M. 1995. Stable and transient transfections in cell cycle studies. In: Cell Cycle -Materials and Methods. M. PAGANO, editor. Springer-Verlag, Berlin. 87-92.
36. O'REILLY, D. R., L. K. MILLER, and V. A. LACKOW. 1992. Baculovirus expression vectors. A laboratory manual. W. H. Freeman and Company, New York. 347 pp.
37. HEUSEN, C., and E. B. DOWDLE. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamid gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196-202.
38. ANDERESON, D. J., and G. BLOBEL. 1983. Immunoprecipitation of proteins from cell-free translations. Methods. Enzymol. 96: 11-120.
39. Hunkapiller, M. W., and E. LUJAN. 1986. Purification of microgram quantities by polyacrylamid gel electrophoresis. In: Methods of protein microcharacterization. J. SHIVELY, editor. Human Press, Clifton, NJ. 89-101.
40. KOZAK, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic promotors. Cell 44: 283-292.
41. COSSINS, J., T. J. DUDGEON, G. CATLIN, A. J. H. GEARING, J. M. CLEMENTS. 1996. Biochem. Biophys. Res. Com. 228: 494-498.
42. PENDÁS, A. M., V. KNÄUPER, X. S., PUENTE, E. LLANO, M. G. MATTEI, S. APTE, G. MURPHY, C. LÓPEZ-OTIN. 1997. J. Biol. Chem. 272: 4281-4286.
43. SPIESS, M. 1995. Head or tails - what determines the orientation of proteins in the membrane. FEBS Lett. 369: 76-79.
44. BROOKS, P. C., STRÖMBLAD, L. C., SANDERS, T. L. VON SCHALSCHA, R. T. AIMES, W. G. STETLER-STEVENSON, J. P. QUIGLEY, and D. A. CHERESH. 1996. Localiziation of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85: 683-693.
45. VAN WART, H., and H. BIRKEDAL-HANSEN. 1990. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-5582.
46. WARD, R. V., S. J. ATKINSON, J. J. REYNOLDS, and G. MURPHY. 1994. Cell Surface mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem. J. 304: 263-269.
47. SATO, H., T. TAKINO, Y. OKADA, J. CAO, A. SHINAGAWA, E. YAMAMOTO, and M. SEIKI. 1994. A matrix metalloprotease expressed on the surface of invasive tumor cells. Nature 370: 61-65.
48. SATO, H., T. TAKINO, T. KINOSHITA, K. IMAI, Y. OKADA, W. G. S. STEVENSON, and M: SAIKI. 1996. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-I-matrix metalloproteinase (MT1-MMP). FEBS Lett. 385: 238-240.
49. BASBAUM, C. B., and Z. WERB. 1996. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell. Biol. 8: 731-738.
50. KOLB, C., S. MAUCH, H.-H. PETER, U. KRAWINKEL, and R. SEDLACEK. 1997. The matrix metalloproteinase RASI-I is expressed in synovial blood vessels of a rheumatoid arthritis patient. Immunol. Lett. 57: 83-88.